Compugen
CGEN
39 hedge funds and large institutions have $25.4M invested in Compugen in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
8% more funds holding
Funds holding: 36 → 39 (+3)
1.06% more ownership
Funds ownership: 19.44% → 20.51% (+1.1%)
41% less capital invested
Capital invested by funds: $42.8M → $25.4M (-$17.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $84K
Top Buyers
Top Sellers
CGEN Hedge Fund Activity: Q4 2018 in Review
39 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Compugen (CGEN) for Q4 2018, worth a combined $25.4M — down 41% from $42.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CGEN positions and 8 closed out — a net gain of 3 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $638K. The largest seller was UBS Group, cutting an estimated $337K.
- 39 institutional investors held Compugen (CGEN) as of Q4 2018, up from 36 in Q3 2018.
- Funds reported $25.4M of Compugen stock for Q4 2018, down 41% quarter-over-quarter.
- 11 funds opened new Compugen positions in Q4 2018 and 8 closed out, a net change of +3 holders.
- The largest Compugen buyer in Q4 2018 was ARK Investment Management, an estimated $638K added.
- The largest Compugen seller in Q4 2018 was UBS Group, an estimated $337K sold.
Based on aggregated 13F filings for Q4 2018.